scholarly journals A Dose of Managed Care: Controlling Drug Spending in Medicaid

2017 ◽  
Author(s):  
David Dranove ◽  
Christopher Ody ◽  
Amanda Starc
Keyword(s):  
1999 ◽  
Vol 18 (2) ◽  
pp. 189-200 ◽  
Author(s):  
Alan L. Hillman ◽  
Mark V. Pauly ◽  
José J. Escarce ◽  
Kimberly Ripley ◽  
Martin Gaynor ◽  
...  

2021 ◽  
Vol 13 (1) ◽  
pp. 170-197
Author(s):  
David Dranove ◽  
Christopher Ody ◽  
Amanda Starc

We study the effect of privatizing Medicaid drug benefits on drug prices and utilization. Drug spending would decrease by 21.3 percent if private insurers administered all drug benefits. One-third of the decrease is driven by private insurers’ ability to negotiate prices with pharmacies. The remaining two-thirds is driven by the greater use of lower cost drugs, such as generics, and is only realized in states that give private insurers the flexibility to design drug benefits. Privatization does not reduce prescriptions per enrollee and spending cuts are smaller for drugs that lower medical spending. (JEL G22, H51, I11, I13, I18, I38, L65)


1997 ◽  
Vol 7 (3) ◽  
pp. 8-10 ◽  
Author(s):  
Becky Sutherland-Cornett ◽  
Bernard P. Henri ◽  
Brooke Hallowell

ASHA Leader ◽  
2016 ◽  
Vol 21 (8) ◽  
pp. 24-25
Author(s):  
Havens Laurie Alban
Keyword(s):  

2006 ◽  
Vol 175 (4S) ◽  
pp. 464-465
Author(s):  
Michael J. Naslund ◽  
Muta M. Issa ◽  
Libby Black ◽  
Michael Eaddy ◽  
Manan Shah

2005 ◽  
Vol 173 (4S) ◽  
pp. 28-28 ◽  
Author(s):  
J. Quentin Clemens ◽  
Richard T. Meenan ◽  
Maureen C. O'Keeffe Rosetti ◽  
Sara Y. Gao ◽  
Elizabeth A. Calhoun

2004 ◽  
Vol 171 (4S) ◽  
pp. 244-244
Author(s):  
John Lavelle ◽  
Libby Black ◽  
Elizabeth Anne Davis
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document